Ingo Schmitz

Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke.

Universitätsklinikum Essen A.d.ö.R. is a top-rated hospital located in Essen, Germany. The hospital is part of the Universitätsmedizin Essen hospital network, which includes 15 other subsidiaries such as the Ruhrlandklinik, St. Josef Krankenhaus Werden, Herzchirurgie Huttrop, and Westdeutsche Protonentherapiezentrum Essen. The hospital network employs approximately 11,000 people and has 1,700 beds.

Novozymes Berlin GmbH operates as a research and development company. It focuses on products and processes derived from microbial strains. The company was founded in 2001 and is headquartered in Berlin, Germany.

Helmholtz Zentrum München Deutsches Forschungszentrum engages in the operation of a research institution for environmental health. Its activities include research focusing on the interaction of genetics, environmental factors, and lifestyle as well as the development of strategies and applications for the diagnosis, treatment, and prevention of serious common diseases. The company was founded in 1960 and is headquartered in Neuherberg, Germany.

German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.